10x Genomics, Inc.TXGNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$130.12M
↑ 298% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-65.58M
Historical baseline
PeriodValueYoY Change
2025$130.12M+2371.2%
2024$-5.73M+91.1%
2023$-64.72M+60.8%
2022$-165.27M-34.7%
2021$-122.65M+52.1%
2020$-256.29M-3048.6%
2019$-8.14M+90.2%
2018$-83.12M-475.0%
2017$-14.46M-